- $24.01m
- $22.55m
- $1.34m
- 43
- 60
- 97
- 74
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 1.21 | 1.69 | 1.34 |
Cost of Revenue | |||||
Gross Profit | — | — | 0.945 | 1.27 | 0.98 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1.43 | 1.99 | 19.1 | 6.35 | 5.66 |
Operating Profit | -1.43 | -1.99 | -17.9 | -4.65 | -4.32 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.64 | -2.56 | -16 | -15.9 | 7.82 |
Net Income After Taxes | -1.64 | -2.56 | -16 | -15.9 | 7.82 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.64 | -2.56 | -16 | -15.9 | 7.82 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.74 | -2.56 | -21.1 | -15.9 | 7.82 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.09 | -0.857 | -2.52 | -1.25 | 0.555 |
Special Dividends per Share |